Spinosyn formulations for treatment of Demodex-induced ocular and facial conditions Grant US-11254701-B2 United States of America 22 Feb 2022
Spinosyn formulations for treatment of demodex-induced ocular and facial conditions Grant US-10730901-B2 United States of America 04 Aug 2020
SPINOSYN FORMULATIONS FOR TREATMENT OF DEMODEX-INDUCED OCULAR AND FACIAL CONDITIONS Application WO-2020023943-A1 World Intellectual Property Organisation (WIPO) 30 Jan 2020